Latest Graft-versus-host disease Stories
AMSTERDAM, October 30, 2014 /PRNewswire/ -- Kiadis Pharma B.V.
AMSTERDAM, September 3, 2014 /PRNewswire/ -- ~ Clinical and Business Development expert re-joins the Company ~ Kiadis Pharma B.V.
MarketOptimizer.org adds “OpportunityAnalyzer Graft-Versus-Host Disease – Opportunity Analysis and Forecasts to 2018” to its store.
ReportsnReports.com adds “EpiCast Report Graft-Versus-Host Disease - Epidemiology Forecast to 2023” to its store.
Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease.
Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease.
Research demonstrates association between diversity of gut bacteria and survival WASHINGTON, June 17, 2014 /PRNewswire-USNewswire/ -- New
NewYork-Presbyterian/Columbia University Medical Center has opened the Irving Bone Marrow Transplant Unit, a state-of-the-art facility for comprehensive bone marrow transplant (BMT) care.
PRINCETON, N.J., March 26, 2014 /PRNewswire/ -- Soligenix, Inc.
AMSTERDAM, March 24, 2014 /PRNewswire/ -- Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.